BRD2 and ovarian hyperstimulation syndrome: The first feedback is an increase in gonadotrophins (LH and FSH) production, the so called “flare-up effect” [73], which might be responsible for an adverse iatrogenic complication, known as Ovarian Hyperstimulation Syndrome (OHSS) [74].